[The use of rifamycin SV as a method of venous perfusion in tuberculotics with liver diseases].
D000995:Antitubercular Agents / Q000009:adverse effects*; D006801:Humans; D008107:Liver Diseases / Q000150:complications*; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*
D000995:Antitubercular Agents; D012293:Rifampin
L'impiego della rifamicina SV col metodo della perfusione venosa nei tubercolotici epatolesi.